SCHEMBL7304627

SCHEMBL7304627

CC[C@H](C)[C@H](NC(=O)OCc1ccccn1)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)OCc1cccnc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.53
CYP3A4 P08684 5/20 0.51
REN P00797 6/20 0.49
CTSL P07711 1/20 0.46
CTSB P07858 1/20 0.46
CTSS P25774 1/20 0.46
BACE1 P56817 1/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
SLC22A2 O15244 1/20 0.43
SLC22A1 O15245 1/20 0.43
ABCC3 O15438 1/20 0.43
ABCC4 O15439 1/20 0.43
MLNR O43193 1/20 0.43
NR1I2 O75469 1/20 0.43
SLCO2B1 O94956 1/20 0.43
ABCB11 O95342 1/20 0.43
ALDH1A1 P00352 1/20 0.43
PGR P06401 1/20 0.43
ABCB1 P08183 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7307582 0.97 CA2 (0.53) CA2CYP3A4RENCTSLCTSB
SCHEMBL13240259 0.93 CA2 (0.62) CA2CYP3A4RENBACE1MEN1
SCHEMBL2771252 0.93 CA2 (0.62) CA2CYP3A4RENBACE1MEN1
SCHEMBL7301274 0.92 CA2 (0.61) CA2CYP3A4RENCTSLCTSB
SCHEMBL7307766 0.91 CA2 (0.68) CA2CYP3A4RENBACE1MEN1
SCHEMBL7300158 0.90 CA2 (0.62) CA2CYP3A4RENBACE1MEN1
SCHEMBL7298711 0.88 CA2 (0.68) CA2CYP3A4RENMEN1KMT2A
SCHEMBL7302088 0.87 CA2 (0.62) CA2CYP3A4RENBACE1MEN1
SCHEMBL7312307 0.86 CYP3A4 (0.58) CA2CYP3A4RENCTSLCTSB
SCHEMBL29379352 0.85 CYP3A4 (0.50) CA2CYP3A4RENCTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US claimed
EP-0486948-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 2000-10-04 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed